Sumary of US offers investment to boost global Covid vaccine capacity:
- : Pressed to address gaping inequality in global Covid-19 vaccines, the Biden administration took steps Wednesday to make billions of dollars available to drugmakers to scale up domestic production to share with the world and prepare for the next pandemic.
- The White House hopes the move will build capacity to produce an additional 1 billion shots per year.
- The initiative comes as the Biden White House has faced growing pressure at home and abroad over inequity in the global vaccine supply — as the US moves toward approving booster shots for all adults while vulnerable people in poorer nations wait for their first dose of protection.
- The Biden administration believes increasing capacity of Covid-19 shots will help ease a global shortage of doses, particularly in lower- and middle-income nations, stopping preventable death and limiting the development of potentially new, more dangerous variants of the virus.
- “The goal of this program is to expand existing capacity by an additional billion doses per year, with production starting by the second half of 2022,” White House Covid-19 coordinator Jeff Zients said.
- The administration is prioritizing the mRNA vaccines, which have proven to be more effective against preventing serious illness and death from Covid-19 than the Johnson &
- Johnson viral vector vaccine, which uses a harmless virus that carries genetic material to stimulate the immune system.
- The Pfizer and Moderna vaccines are made with a piece of genetic code called messenger RNA that tells the body to make harmless copies of the spike protein so it’s trained to recognize the virus.